ArticleCureus2024
A Case of Dengue Fever With Multiserotype IgG Positivity.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue fever is a rapidly spreading mosquito-borne viral disease, increasingly endemic in tropical and subtropical regions. This case report details the clinical presentation of a 52-year-old male who developed severe symptoms shortly after returning from a two-week trip to El Salvador, an area known for dengue endemicity. The patient presented with a five-day history of high-grade fever, malaise, diarrhea, dizziness, and intermittent blurry vision, accompanied by chills, dry cough, headaches, and generalized pain. Physical examination revealed petechiae on the lower extremities, and the Rumpel-Leede test was positive, indicating capillary fragility and suggesting thrombocytopenia consistent with dengue infection. Supportive care, including antipyretics, hydration, and electrolyte management, resolved symptoms by day four, allowing the patient to be discharged. This case underscores the importance of considering dengue in patients with relevant travel history and highlights the increasing global reach of this vector-borne disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.